Should I buy Intuitive Surgical (ISRG) stock or is it too late?
⭐ The most reliable of them, either direction: BMO Capital — 73% of its targets hit on this sector (239 calls tested). It aims for $518 (+41 %), call made on July 10, 2026, maturing on July 10, 2027 (49 d ago).
Firm-by-firm track record on Intuitive Surgical
| Firm | % right | Gain vs sector | Calls | Aims for |
|---|---|---|---|---|
| Raymond James | 82 % | +31.0 % | 22 | $483 +32% |
| Barclays | 92 % | +26.3 % | 12 | $651 +77% |
| Truist Securities | 71 % | +24.6 % | 21 | $510 +39% |
| Stifel | 88 % | +24.6 % | 17 | $550 +50% |
| RBC Capital | 60 % | +22.2 % | 15 | $575 +57% |
| Goldman Sachs | 60 % | +20.6 % | 5 | $609 +66% |
| Wells Fargo | 61 % | +20.5 % | 23 | $487 +33% |
| JP Morgan | 69 % | +20.0 % | 13 | $450 +23% |
✅ Reasons to believe
- 82% of analysts rate it a buy (Buy consensus, 22 ratings) — a sign of market conviction.
- Median price target $500, i.e. +36% from the current price ($367).
- The most reliable firm on ISRG, Bernstein (100% hit rate, 3 scored calls), targets $685 (call made on July 17, 2026, maturing on July 17, 2027) (+87%) in its most recent call, and $740 (call made on January 9, 2026, maturing on January 9, 2027) (+102%) in the one coming due soonest.
- 14 analysts rated reliable (≥55% hit rate, beat their sector) are bullish on the stock.
⚠️ Reasons to hesitate
- The consensus is not unanimous: of 22 ratings, 4 are neutral.
- High valuation (P/E ~43): strong growth is already "priced in", leaving little room for error.
- A 12-month target is not a guaranteed path: the price can fall in the meantime.
- No dividend: your return depends only on price appreciation.
The analyst consensus on ISRG
Median target $500 (+36%) · 22 ratings · Buy consensus
⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.
Frequently asked questions
Should you invest in Intuitive Surgical now?
We won't decide for you. The facts: 82% of analysts rate it a buy, median target $500 (+36%), and Bernstein (most reliable on ISRG, 100%) targets $685. Weigh that against valuation (P/E ~43). This is not personalized advice.
Is it too late to invest in Intuitive Surgical?
Not according to analysts: the median target ($500) is still +36% above the current price ($367) (most reliable on ISRG: Bernstein, 100%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.
Is Intuitive Surgical still worth investing in?
It depends on the gap between the price ($367) and its estimated value: analysts target $500 on median (+36%), with 82% buys (most reliable on ISRG: Bernstein, 100%). Cross-check with their real reliability on ISRG and the cautions above. Information, not advice.
What's the main risk in buying ISRG?
The consensus is not unanimous: of 22 ratings, 4 are neutral.
→ Go deeper: the full Intuitive Surgical profile (consensus, analyst reliability, price target, performance).